Services
Introduction
IBGE has transformed biomedical research from bench-top to the bedside for addressing shadowed issues in the healthcare sector at national and international level. The institute is fully equipped with state-of-the-art latest technologies to conduct reasonably wholesome genetics, molecular biology and biomedical deliverable R&D.
In the growing body of biomedical and genetic services at IBGE, there are more than one hundred and fifty genetic and molecular biology-based health services for disease diagnosis, prognosis, perdition, recurrence, therapeutics and organ and bone-marrow transplantation. And there is an ongoing accumulation of R&D deliverables in the services fleet to meet almost every healthcare concern in the country and across.
Goal
To ensure quality deliverability & adaptation of output through institutional R&D in the healthcare, pharma, academics, science and technology policy making sectors.
Maximize the adaptation of scientific and technical achievements by bridging the biomedical, genetics, molecular biology, healthcare and pharma industry sectors.
Present Work
The classified and exclusively established range of genetic and molecular biology services at IBGE include:
- HLA Typing
- DNA forensics & human identification
- Regenerative Medicine
- Rare genetic diseases and syndromes
- Classical cytogenetics and chromosomal breakage analysis
- Molecular cytogenetics
- Cancer biomarkers
- DNA synthesis
- Genetic screening for successful kidney transplantation.
- Male infertility
- Prenatal diagnosis
- DNA sequencing
- Genetic diseases
- Infectious diseases
- Prenatal genetic testing
In addition, the group has international collaboration with DKMS Life Science Lab, Germany for high resolution HLA typing.
Future Work
- Establishment of Bone Marrow Donor Registry (BMDR)
- Expansion of FISH based molecular diagnostics and R&D services
- Tissue Cytogenetics
- NGS and Microarray services